SMT Engineering FY26 Consolidated Profit Rs 23.08 Cr; Raises Rs 34.87 Cr

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
SMT Engineering FY26 Consolidated Profit Rs 23.08 Cr; Raises Rs 34.87 Cr
Overview

SMT Engineering reported strong consolidated financials for FY26 with a profit of Rs 23.08 crore. The company also raised Rs 34.87 crore via a preferential issue. Investors should focus on consolidated figures and monitor governance compliance following a BSE fine.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

SMT Engineering Posts Rs 23.08 Cr Consolidated Profit for FY26, Raises Funds

SMT Engineering Limited reported a consolidated profit after tax of ₹23.08 crore for the financial year ended March 31, 2026. The company's consolidated revenue from operations stood at ₹162.24 crore for the same period.

Reader Takeaway: Strong consolidated growth and capital infusion balanced by a past compliance fine.

What Just Happened

SMT Engineering Limited announced its audited standalone and consolidated financial results for the fiscal year 2026. The company reported a consolidated profit for the period of ₹23.08 crore on revenue from operations of ₹162.24 crore. For the fourth quarter of FY26, consolidated profit stood at ₹12.06 crore on revenue of ₹74.10 crore.

Additionally, the company secured ₹34.87 crore by issuing 15.50 lakh equity shares at ₹225 per share through a preferential issue. The authorized share capital was also increased from ₹17 crore to ₹18.10 crore.

Why This Matters

The consolidated figures highlight the company's overall financial performance, which is significantly larger than its standalone operations, due to its subsidiaries, Sai Machine Tools Private Limited and Chemerix Life Sciences Private Limited. The capital raised through the preferential issue can be used for expansion or strengthening the balance sheet, while the increase in authorized capital supports future equity issuances.

The Backstory

For FY26, standalone revenue was ₹1.90 crore with a profit of ₹0.50 crore. In contrast, consolidated revenue reached ₹162.24 crore and profit ₹23.08 crore, underscoring the contribution of its subsidiaries.

What Changes Now

The infusion of ₹34.87 crore from the preferential issue will bolster the company's financial resources. Investors should note the governance aspect, as the company disclosed a fine levied by the BSE for non-compliance with Regulation 23(9) concerning related party transactions for the half-year ended September 2025.

Risks to Watch

While the statutory auditors provided an unmodified opinion, indicating no major concerns with the financial statements, the BSE fine serves as a governance watch point. Investors will be keen to see improvements in compliance with disclosure norms.

Peer Comparison

(No peer comparison data available in the filing.)

Context Metrics (Time-bound)

  • FY26 Consolidated Revenue: ₹162.24 crore
  • FY26 Consolidated Profit: ₹23.08 crore
  • Q4 FY26 Consolidated Revenue: ₹74.10 crore
  • Q4 FY26 Consolidated Profit: ₹12.06 crore
  • Capital Raised (Preferential Issue): ₹34.87 crore

What to Track Next

Investors should monitor future disclosures regarding related party transactions and overall compliance with BSE regulations. Tracking the utilization of funds raised and the performance of subsidiaries will also be crucial.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.